Small cell lung cancer trials in the EORTC.
An overview of activities of the EORTC Lung Cancer Coöperative Group in small cell lung cancer is given. Optimal length of therapy, identification of patients with good/bad prognostic factors, role of surgery and the study of new drugs presently are the main areas of interest for the group. With its large patient potential the group is able to verify "early favourable reports" and to quickly perform phase II studies.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery
D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide